ES2925098T3
(es )
2022-10-13
Activador triple que activa el receptor de glucagón, GLP-1 Y GIP
WO2020150552A2
(en )
2020-07-23
Methods of treating cartilage disorders through inhibition of clk and dyrk
AU2001272735A1
(en )
2002-01-30
Novel physiologically active peptide and use thereof
CA2529179A1
(en )
2004-12-23
Recombinant adeno-associated virus vector for treatment of alzheimer disease
US20100158905A1
(en )
2010-06-24
Combination therapy of arthritis with tranilast
JP2009514954A
(ja )
2009-04-09
Trpv3機能を変調するための化合物
FI3294345T3
(fi )
2024-01-15
Tpp1-formulaatioita ja menetelmiä cln2-taudin hoitamiseksi
KR20060054174A
(ko )
2006-05-22
항-아밀로이드 항체, 조성물, 방법 및 용도
GB0211649D0
(en )
2002-07-03
Organic compounds
BR0309553A
(pt )
2005-02-09
Composto ou sal farmaceuticamente aceitável ou éster ou amida hidrolisável in vivo deste, processo para prepará-lo, composição farmacêutica, uso do composto, e, métodos para produzir um efeito inibidor de hdac em um animal de sangue quente, e para tratar câncer em um animal de sangue quente
WO2005040418A3
(en )
2005-11-10
Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt
JP2024056875A
(ja )
2024-04-23
疼痛を処置するためにフェノキシプロピルアミン化合物を使用する方法
TW200732351A
(en )
2007-09-01
New cyclic peptide compounds
RU2006131553A
(ru )
2008-03-10
Комбинация(а) ингибитора топоизомеразы днк и (б) ингибитора iap
JP2006158399A5
(ja )
2007-10-11
細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
JP2010533660A5
(enExample )
2012-07-05
JP2024525515A
(ja )
2024-07-12
がんの予防用又は治療用の医薬組成物
WO2003014703A3
(en )
2005-05-19
Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
JP2008522632A5
(enExample )
2008-11-27
JP2022515721A5
(enExample )
2022-12-19
YU60199A
(sh )
2002-09-19
Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
JP2025503251A5
(enExample )
2026-02-04
WO2002062944A3
(fr )
2002-10-03
Nouveau peptide physiologiquement actif et son utilisation
JP2002355060A5
(enExample )
2005-06-16
JP2007517775A5
(enExample )
2007-11-22